American Cancer Patients Pay Twice As Much For Drugs As Europeans

By Ben Hirschler

LONDON (Reuters) - Americans are paying way over the odds for some modern cancer drugs, with pharmaceutical companies charging up to 600 times what the medicines cost to make, according to an independent academic study.

The United States also pays more than double the price charged in Europe for these drugs - so-called tyrosine kinase inhibitors (TKIs), a potent class of cancer pills with fewer side effects than chemotherapy.

The analysis by pharmacologist

What feeling does this article give you?

#hashtags to follow:

Ben Hirschler [+]    LONDON [+]    Reuters [+]    Americans [+]    United States [+]    Europe [+]    TKIs [+]   

More #news: